Aldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape

The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. Th...

Full description

Saved in:
Bibliographic Details
Published in:Chembiochem : a European journal of chemical biology Vol. 24; no. 11; pp. e202300205 - n/a
Main Authors: Voskoboinyk, Dmytro, Mahmoodi, Niusha, Lin, Chang Sheng‐Huei, Murphy, Michael E. P., Tanner, Martin E.
Format: Journal Article
Language:English
Published: Germany Wiley Subscription Services, Inc 01-06-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition. Aldehyde‐based inhibitors of the peptidoglycan deacetylase Ape were shown to act as competitive inhibitors with Ki values in the low micromolar range. Reduction of the aldehyde to an alcohol abolishes inhibition, suggesting that the binding may involve the formation of a tetrahedral adduct with the active site serine nucleophile.
AbstractList The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition. Aldehyde‐based inhibitors of the peptidoglycan deacetylase Ape were shown to act as competitive inhibitors with Ki values in the low micromolar range. Reduction of the aldehyde to an alcohol abolishes inhibition, suggesting that the binding may involve the formation of a tetrahedral adduct with the active site serine nucleophile.
Abstract The O ‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O ‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni . The most potent of these acts as a competitive inhibitor with a K i value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
The O-acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram-negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O-acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine-linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde-based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a K value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In Gram‐negative bacteria, deacetylation is required to allow lytic transglycosylases to promote PG cleavage during cell growth and division. This deacetylation is catalyzed by O‐acetylpeptidoglycan esterase (Ape) which is a serine esterase and employs covalent catalysis via a serine‐linked acyl enzyme intermediate. Loss of Ape activity affects the size and shape of bacteria and dramatically reduces virulence. In this work, we report the first rationally designed aldehyde‐based inhibitors of Ape from Campylobacter jejuni. The most potent of these acts as a competitive inhibitor with a Ki value of 13 μM. We suspect that the inhibitors are forming adducts with the active site serine that closely mimic the tetrahedral intermediate of the normal catalytic cycle. Support for this notion is found in the observation that reduction of the aldehyde to an alcohol effectively abolishes the inhibition.
Author Mahmoodi, Niusha
Voskoboinyk, Dmytro
Tanner, Martin E.
Lin, Chang Sheng‐Huei
Murphy, Michael E. P.
Author_xml – sequence: 1
  givenname: Dmytro
  surname: Voskoboinyk
  fullname: Voskoboinyk, Dmytro
  organization: University of British Columbia
– sequence: 2
  givenname: Niusha
  surname: Mahmoodi
  fullname: Mahmoodi, Niusha
  organization: University of British Columbia
– sequence: 3
  givenname: Chang Sheng‐Huei
  orcidid: 0000-0002-6966-4417
  surname: Lin
  fullname: Lin, Chang Sheng‐Huei
  organization: University of British Columbia
– sequence: 4
  givenname: Michael E. P.
  orcidid: 0000-0003-2589-0014
  surname: Murphy
  fullname: Murphy, Michael E. P.
  organization: University of British Columbia
– sequence: 5
  givenname: Martin E.
  orcidid: 0000-0002-3224-3491
  surname: Tanner
  fullname: Tanner, Martin E.
  email: mtanner@chem.ubc.ca
  organization: University of British Columbia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37069132$$D View this record in MEDLINE/PubMed
BookMark eNqF0EFLwzAUB_AgE-emV49S8OKlM8lr0_TYFZ2DwTzoubTJq-vo2tp0SG9-BD-jn8SMzQlePOUFfu_P4z8ig6qukJArRieMUn6nskJNOOVgP9Q_IefMg9ANBMDgMHucB0MyMmZNKQ0FsDMyhICKkAE_J7Oo1LjqNX59fE5Tg9qZV6siK7q6NU6dO90KnSdsukLXr2Wv0spZWhkp7PoSTYet3XGiBi_IaZ6WBi8P75i8PNw_x4_uYjmbx9HCVSCk7yoBgZ97kqqM-VJnwDnNNVABPMs9yP0gBPAEYMAgDQPFPK1SqaUWQZhzFcKY3O5zm7Z-29oLkk1hFJZlWmG9NQmXlEspGPUsvflD1_W2rex1VnHGhSc5tWqyV6qtjWkxT5q22KRtnzCa7CpOdhUnx4rtwvUhdpttUB_5T6cWhHvwXpTY_xOXxNN5_Bv-DZM7iTE
Cites_doi 10.1016/j.biocel.2007.03.018
10.1074/jbc.M114.567388
10.1021/bi700254m
10.1111/mmi.12153
10.1021/jo102329c
10.1128/IAI.73.9.5697-5705.2005
10.1021/bi051679s
10.1146/annurev-micro-020518-120056
10.3389/fmicb.2018.02332
10.1111/j.1574-6976.2007.00088.x
10.1080/10409238.2017.1337705
10.1021/acs.chemrev.1c00773
10.1002/cbic.201100744
10.1074/jbc.M112.436352
10.1074/jbc.M116.746404
10.1371/journal.ppat.1006512
10.1111/j.1574-6976.2007.00094.x
10.1074/jbc.M110.107086
10.1107/S1399004714016770
10.1006/bioo.1993.1021
ContentType Journal Article
Copyright 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH
2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.
2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH
– notice: 2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.
– notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
WIN
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7QO
7TM
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
DOI 10.1002/cbic.202300205
DatabaseName Open Access: Wiley-Blackwell Open Access Journals
Wiley Free Archive
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Virology and AIDS Abstracts
Biotechnology Research Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
Virology and AIDS Abstracts
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1439-7633
EndPage n/a
ExternalDocumentID 10_1002_cbic_202300205
37069132
CBIC202300205
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Natural Sciences and Engineering Research Council of Canada (NSERC)
– fundername: Canadian Institutes of Health Research (CIHR)
  funderid: MOP-142176
– fundername: Canadian Institutes of Health Research (CIHR)
  grantid: MOP-142176
GroupedDBID ---
-DZ
-~X
05W
0R~
1L6
1OC
24P
29B
33P
3WU
4.4
4ZD
50Y
5GY
5VS
66C
6J9
6P2
77Q
8-0
8-1
8UM
A00
AAESR
AAHHS
AAIHA
AANLZ
AAXRX
AAZKR
ABCUV
ABIJN
ABJNI
ABLJU
ACAHQ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACPRK
ACXBN
ACXQS
ADBBV
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFRAH
AFZJQ
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMYDB
AZVAB
BDRZF
BFHJK
BMXJE
BRXPI
CS3
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EMOBN
F5P
G-S
GNP
HBH
HGLYW
HHY
HHZ
HZ~
IH2
IX1
JPC
KQQ
LATKE
LAW
LEEKS
LITHE
LOXES
LUTES
LYRES
MEWTI
MXFUL
MXSTM
MY~
NNB
O9-
OIG
P2P
P2W
P4E
PQQKQ
R.K
ROL
RWI
RX1
SUPJJ
SV3
V2E
W99
WBKPD
WH7
WIN
WJL
WOHZO
WXSBR
WYJ
XPP
XV2
Y6R
YZZ
ZZTAW
~KM
~S-
CGR
CUY
CVF
ECM
EIF
NPM
.GJ
31~
53G
AASGY
AAYXX
ACBWZ
AFFNX
AI.
ASPBG
AVWKF
AZFZN
CITATION
EJD
FEDTE
GODZA
HVGLF
VH1
XSW
ZGI
7QL
7QO
7TM
7U9
8FD
C1K
FR3
H94
K9.
M7N
P64
7X8
ID FETCH-LOGICAL-c3685-c6375f480cb158db3220fd30632bf43f57933463e713a97c14dca8d8d679f2c93
IEDL.DBID 33P
ISSN 1439-4227
IngestDate Thu Jul 25 10:58:14 EDT 2024
Thu Oct 10 20:26:12 EDT 2024
Fri Aug 23 03:03:26 EDT 2024
Sat Sep 28 08:14:21 EDT 2024
Sat Aug 24 00:46:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords antibiotic
N-acetylmuramic acid
peptidoglycan
reversible covalent inhibitor
esterase
Campylobacter jejuni
Language English
License Attribution-NonCommercial
2023 The Authors. ChemBioChem published by Wiley-VCH GmbH.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3685-c6375f480cb158db3220fd30632bf43f57933463e713a97c14dca8d8d679f2c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2589-0014
0000-0002-3224-3491
0000-0002-6966-4417
OpenAccessLink https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202300205
PMID 37069132
PQID 2821264820
PQPubID 986344
PageCount 8
ParticipantIDs proquest_miscellaneous_2802886104
proquest_journals_2821264820
crossref_primary_10_1002_cbic_202300205
pubmed_primary_37069132
wiley_primary_10_1002_cbic_202300205_CBIC202300205
PublicationCentury 2000
PublicationDate June 1, 2023
2023-06-01
2023-06-00
20230601
PublicationDateYYYYMMDD 2023-06-01
PublicationDate_xml – month: 06
  year: 2023
  text: June 1, 2023
  day: 01
PublicationDecade 2020
PublicationPlace Germany
PublicationPlace_xml – name: Germany
– name: Weinheim
PublicationTitle Chembiochem : a European journal of chemical biology
PublicationTitleAlternate Chembiochem
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2022; 122
2019; 8
2018; 9
2017; 52
2014; 70
2021; 75
2006; 45
2013; 87
2021
1993; 21
2017; 13
2005; 73
2013; 288
2010; 285
2011; 76
2008; 32
2008; 40
2016; 291
2012; 13
2007; 46
2022; 28
2014; 289
e_1_2_7_6_1
e_1_2_7_5_1
e_1_2_7_4_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_8_1
e_1_2_7_19_1
e_1_2_7_18_1
e_1_2_7_17_1
e_1_2_7_16_1
e_1_2_7_2_1
e_1_2_7_15_1
e_1_2_7_1_1
e_1_2_7_14_1
e_1_2_7_12_1
e_1_2_7_23_1
e_1_2_7_11_1
e_1_2_7_22_1
e_1_2_7_10_1
e_1_2_7_20_1
Brott A. S. (e_1_2_7_7_1) 2019; 8
Lin C. S. H. (e_1_2_7_13_1) 2021
Vacariu C. M. (e_1_2_7_21_1) 2022; 28
References_xml – volume: 52
  start-page: 503
  year: 2017
  end-page: 542
  publication-title: Crit. Rev. Biochem. Mol. Biol.
– volume: 75
  start-page: 315
  year: 2021
  end-page: 336
  publication-title: Annu. Rev. Microbiol.
– volume: 288
  start-page: 2605
  year: 2013
  end-page: 2613
  publication-title: J. Biol. Chem.
– volume: 32
  start-page: 287
  year: 2008
  end-page: 306
  publication-title: FEMS Microbiol. Rev.
– volume: 32
  start-page: 149
  year: 2008
  end-page: 167
  publication-title: FEBS Microbiol. Rev.
– volume: 122
  start-page: 8884
  year: 2022
  end-page: 8910
  publication-title: Chem. Rev.
– volume: 73
  start-page: 5697
  year: 2005
  end-page: 5705
  publication-title: Infect. Immun.
– volume: 87
  start-page: 1100
  year: 2013
  end-page: 1112
  publication-title: Mol. Microbiol.
– volume: 13
  year: 2017
  publication-title: PLoS Pathog.
– volume: 46
  start-page: 4932
  year: 2007
  end-page: 4941
  publication-title: Biochemistry
– volume: 289
  start-page: 16748
  year: 2014
  end-page: 16760
  publication-title: J. Biol. Chem.
– volume: 76
  start-page: 1118
  year: 2011
  end-page: 1125
  publication-title: J. Org. Chem.
– volume: 13
  start-page: 722
  year: 2012
  end-page: 731
  publication-title: ChemBioChem
– year: 2021
  publication-title: bioRxiv
– volume: 70
  start-page: 2631
  year: 2014
  end-page: 2639
  publication-title: Acta Crystallogr. Sect. D
– volume: 28
  year: 2022
  publication-title: Chem. Eur. J.
– volume: 8
  year: 2019
  publication-title: Antibiotics-Basel.
– volume: 21
  start-page: 249
  year: 1993
  end-page: 259
  publication-title: Bioorg. Chem.
– volume: 291
  start-page: 22686
  year: 2016
  end-page: 22702
  publication-title: J. Biol. Chem.
– volume: 9
  year: 2018
  publication-title: Front. Microbiol.
– volume: 285
  start-page: 13264
  year: 2010
  end-page: 13273
  publication-title: J. Biol. Chem.
– volume: 40
  start-page: 586
  year: 2008
  end-page: 591
  publication-title: Int. J. Biochem. Cell Biol.
– volume: 45
  start-page: 839
  year: 2006
  end-page: 851
  publication-title: Biochemistry
– ident: e_1_2_7_9_1
  doi: 10.1016/j.biocel.2007.03.018
– ident: e_1_2_7_12_1
  doi: 10.1074/jbc.M114.567388
– ident: e_1_2_7_15_1
  doi: 10.1021/bi700254m
– ident: e_1_2_7_18_1
  doi: 10.1111/mmi.12153
– year: 2021
  ident: e_1_2_7_13_1
  publication-title: bioRxiv
  contributor:
    fullname: Lin C. S. H.
– ident: e_1_2_7_20_1
  doi: 10.1021/jo102329c
– ident: e_1_2_7_10_1
  doi: 10.1128/IAI.73.9.5697-5705.2005
– ident: e_1_2_7_14_1
  doi: 10.1021/bi051679s
– ident: e_1_2_7_3_1
  doi: 10.1146/annurev-micro-020518-120056
– ident: e_1_2_7_6_1
  doi: 10.3389/fmicb.2018.02332
– ident: e_1_2_7_5_1
  doi: 10.1111/j.1574-6976.2007.00088.x
– ident: e_1_2_7_8_1
  doi: 10.1080/10409238.2017.1337705
– volume: 28
  year: 2022
  ident: e_1_2_7_21_1
  publication-title: Chem. Eur. J.
  contributor:
    fullname: Vacariu C. M.
– volume: 8
  year: 2019
  ident: e_1_2_7_7_1
  publication-title: Antibiotics-Basel.
  contributor:
    fullname: Brott A. S.
– ident: e_1_2_7_1_1
  doi: 10.1021/acs.chemrev.1c00773
– ident: e_1_2_7_23_1
  doi: 10.1002/cbic.201100744
– ident: e_1_2_7_17_1
  doi: 10.1074/jbc.M112.436352
– ident: e_1_2_7_19_1
  doi: 10.1074/jbc.M116.746404
– ident: e_1_2_7_4_1
  doi: 10.1371/journal.ppat.1006512
– ident: e_1_2_7_2_1
  doi: 10.1111/j.1574-6976.2007.00094.x
– ident: e_1_2_7_11_1
  doi: 10.1074/jbc.M110.107086
– ident: e_1_2_7_16_1
  doi: 10.1107/S1399004714016770
– ident: e_1_2_7_22_1
  doi: 10.1006/bioo.1993.1021
SSID ssj0009631
Score 2.440143
Snippet The O‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In...
The O-acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of lysozyme. In...
Abstract The O ‐acetylation of the muramic acid residues in peptidoglycan (PG) is a modification that protects the bacteria from lysis due to the action of...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e202300205
SubjectTerms Acetylation
Acetylesterase
Adducts
Aldehydes
Aldehydes - pharmacology
Animals
antibiotic
Bacteria
Bacteria - metabolism
Campylobacter jejuni
Catalysis
Deacetylation
esterase
Esterases - chemistry
Gram-negative bacteria
Hominidae - metabolism
Inhibitors
Lysis
Lysozyme
N-acetylmuramic acid
peptidoglycan
Peptidoglycan - chemistry
Peptidoglycans
reversible covalent inhibitor
Serine
Serine esterase
Virulence
Title Aldehyde‐Based Inhibitors of the Peptidoglycan O‐Acetylesterase Ape
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fcbic.202300205
https://www.ncbi.nlm.nih.gov/pubmed/37069132
https://www.proquest.com/docview/2821264820
https://search.proquest.com/docview/2802886104
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB5BL3AB2gINFGQkVE5RE9vxzzFdWtoLVGorcYviP7rSNlt1u4e99RH6jDwJY2c31aoHJLglip1YM5nMN87MNwCfqbaB-sLktPQ6R3_Nc92akFPeCulaJqSM9c7HZ_L7T_X1MNLkDFX8PT_EsOEWLSN9r6OBt2a2_0Aaas04UhAihEbEE6vMMVRINRzs9IF1V6SGhIgJ4jqoXLE2FnR_ffq6V3oENdeRa3I9Ry__f9Gv4MUSdpK6f0824YnvtmC77jDkvlqQPZISQdMO-xY8G62awG3Dt3ri_OXC-d939wfo8Bw56S7HZhx79JBpIAgfyWlMjHHTX5MFqon8wJG19beLSeJgwDmkvvav4eLo8Hx0nC97L-Q2UtLnVjBZBa4Ka8pKOYN2XwSH8QWjJnAWKrRrxgXzGOS2WtqSO9sqp5yQOlCr2RvY6Kad3wGifNVqwYvgjeZlEMYY4TFqwrspVQmTwZeV7JvrnmKj6cmUaRPl1QzyymB3pZpmaWqzBmPGMqbp0SKDT8NlFFP889F2fjqPYxBGKUSKPIO3vUqHRzFZCI0xeQY0ae4va2hGByej4ezdv0x6D8_jcZ9wtgsbtzdz_wGeztz8Y3p9_wBib-0-
link.rule.ids 315,782,786,1408,27935,27936,46066,46490
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB7RcigXHi2UlAJGQnCKmtiOH8d0adkVpVSiSNyi-EVXWrJV2z3sjZ_Ab-SXME42qVYckBDHJHZizXgy39jjbwBeU20D9ZlJae51iv6ap7o2IaW8FtLVTEgZzzuPP8vTr-rdUaTJKfuzMB0_xLDgFi2j_V9HA48L0ge3rKHWTCMHIWJohDzFBtzlgutYvYGxs1veXdGWJERUEEdCZc_bmNGD9f7rfukPsLmOXVvnc_zgPwz7IdxfIU9SdlPlEdzxzTbslA1G3d-X5A1pc0HbRfZt2Br1deB24H05c_5i6fyvHz8P0ec5MmkupmYay_SQeSCIIMlZzI1x82-zJWqKfMKWpfU3y1lLw4B9SHnpH8OX46Pz0ThdlV9IbWSlT61gsghcZdbkhXIGTT8LDkMMRk3gLBRo2owL5jHOrbW0OXe2Vk45IXWgVrMnsNnMG_8UiPJFrQXPgjea50EYY4THwAnfplQhTAJve-FXlx3LRtXxKdMqyqsa5JXAfq-bamVt1xWGjXnM1KNZAq-GxyimuPlRN36-iG0QSSkEizyB3U6nw6eYzITGsDwB2qruL2OoRoeT0XC19y-dXsLW-PzjSXUyOf3wDO7F-13-2T5s3lwt_HPYuHaLF-1c_g1f7PFf
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwEB7RIgEXCi2F0BaMhOAUNbEd_xzTbZeuQGUlQOIWxX90pSW7ot3D3ngEnpEnYZzsplpxqATHJHZizXgy39jjbwBeU20D9ZlJae51iv6ap7o2IaW8FtLVTEgZzzuff5IXX9XpWaTJ6U_xd_wQ_YJbtIz2fx0NfO7C8Q1pqDWTSEGIEBoRT7EFd3nE4vEQBxvf0O6KtiIhgoI4ECrXtI0ZPd7sv-mW_sKam9C19T3Dnf8f9SN4uMKdpOwmymO445td2CsbjLm_L8kb0maCtkvsu3B_sK4Ctwfvyqnzl0vnf__8dYIez5FRczkxk1ikh8wCQfxIxjEzxs2-TZeoJ_IRW5bWXy-nLQkD9iHl3D-BL8Ozz4PzdFV8IbWRkz61gskicJVZkxfKGTT8LDgMMBg1gbNQoGEzLpjHKLfW0ubc2Vo55YTUgVrN9mG7mTX-GRDli1oLngVvNM-DMMYIj2ETvk2pQpgE3q5lX807jo2qY1OmVZRX1csrgcO1aqqVrV1VGDTmMU-PZgm86h-jmOLWR9342SK2QRylECryBJ52Ku0_xWQmNAblCdBWc7eMoRqcjAb91fN_6fQS7o1Ph9WH0cX7A3gQb3fJZ4ewff1j4Y9g68otXrQz-Q-JIfAO
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aldehyde%E2%80%90Based+Inhibitors+of+the+Peptidoglycan+O%E2%80%90Acetylesterase+Ape&rft.jtitle=Chembiochem+%3A+a+European+journal+of+chemical+biology&rft.au=Voskoboinyk%2C+Dmytro&rft.au=Mahmoodi%2C+Niusha&rft.au=Lin%2C+Chang+Sheng%E2%80%90Huei&rft.au=Murphy%2C+Michael+E.+P.&rft.date=2023-06-01&rft.issn=1439-4227&rft.eissn=1439-7633&rft.volume=24&rft.issue=11&rft.epage=n%2Fa&rft_id=info:doi/10.1002%2Fcbic.202300205&rft.externalDBID=10.1002%252Fcbic.202300205&rft.externalDocID=CBIC202300205
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1439-4227&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1439-4227&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1439-4227&client=summon